Steve Leung Design Group Ltd
HKEX:2262
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Steve Leung Design Group Ltd
HKEX:2262
|
HK |
|
C
|
Cutia Therapeutics
HKEX:2487
|
CN |
|
B
|
Banco Santander Brasil SA
BOVESPA:SANB3
|
BR |
Income Statement
Earnings Waterfall
Steve Leung Design Group Ltd
Income Statement
Steve Leung Design Group Ltd
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
1
|
1
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
0
|
0
|
|
| Revenue |
504
N/A
|
502
0%
|
505
+1%
|
470
-7%
|
433
-8%
|
459
+6%
|
455
-1%
|
420
-8%
|
381
-9%
|
362
-5%
|
356
-2%
|
362
+2%
|
368
+2%
|
398
+8%
|
423
+6%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(277)
|
(306)
|
(310)
|
(273)
|
(245)
|
(271)
|
(266)
|
(256)
|
(242)
|
(217)
|
(217)
|
(219)
|
(221)
|
(242)
|
(261)
|
|
| Gross Profit |
227
N/A
|
196
-13%
|
195
-1%
|
197
+1%
|
188
-5%
|
188
0%
|
189
+1%
|
165
-13%
|
139
-15%
|
144
+4%
|
139
-3%
|
143
+3%
|
147
+3%
|
156
+6%
|
161
+3%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(129)
|
(133)
|
(133)
|
(122)
|
(138)
|
(129)
|
(186)
|
(201)
|
(191)
|
(182)
|
(152)
|
(143)
|
(129)
|
(134)
|
(138)
|
|
| Selling, General & Administrative |
(129)
|
(142)
|
(141)
|
(132)
|
(149)
|
(154)
|
(192)
|
(202)
|
(193)
|
(181)
|
(153)
|
(142)
|
(131)
|
(138)
|
(143)
|
|
| Depreciation & Amortization |
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
1
|
10
|
9
|
11
|
11
|
26
|
6
|
1
|
3
|
(1)
|
1
|
(1)
|
3
|
4
|
6
|
|
| Operating Income |
98
N/A
|
63
-35%
|
62
-2%
|
75
+22%
|
50
-34%
|
59
+18%
|
3
-95%
|
(37)
N/A
|
(51)
-39%
|
(38)
+26%
|
(12)
+67%
|
(1)
+96%
|
18
N/A
|
21
+22%
|
24
+10%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
6
|
(2)
|
(0)
|
(4)
|
8
|
(4)
|
0
|
(4)
|
(8)
|
(4)
|
(4)
|
(4)
|
(5)
|
(3)
|
(2)
|
|
| Non-Reccuring Items |
(15)
|
(8)
|
(0)
|
0
|
(1)
|
0
|
2
|
0
|
(0)
|
0
|
(1)
|
0
|
(2)
|
0
|
(1)
|
|
| Pre-Tax Income |
88
N/A
|
53
-39%
|
61
+14%
|
72
+17%
|
58
-20%
|
55
-5%
|
6
-90%
|
(41)
N/A
|
(60)
-47%
|
(42)
+30%
|
(17)
+59%
|
(5)
+72%
|
10
N/A
|
19
+82%
|
21
+14%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
(30)
|
(29)
|
(21)
|
(17)
|
(23)
|
(22)
|
(4)
|
2
|
(0)
|
0
|
(3)
|
(5)
|
(9)
|
(9)
|
(11)
|
|
| Income from Continuing Operations |
58
|
24
|
40
|
55
|
35
|
32
|
2
|
(39)
|
(60)
|
(42)
|
(20)
|
(10)
|
1
|
10
|
10
|
|
| Income to Minority Interest |
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
1
|
1
|
(3)
|
(1)
|
1
|
2
|
1
|
(0)
|
1
|
|
| Net Income (Common) |
57
N/A
|
23
-59%
|
39
+67%
|
53
+38%
|
34
-37%
|
31
-7%
|
3
-91%
|
(38)
N/A
|
(62)
-66%
|
(43)
+31%
|
(19)
+56%
|
(8)
+59%
|
2
N/A
|
10
+428%
|
11
+17%
|
|
| EPS (Diluted) |
0.06
N/A
|
0.02
-67%
|
0.03
+50%
|
0.05
+67%
|
0.03
-40%
|
0.03
N/A
|
0
N/A
|
-0.03
N/A
|
-0.05
-67%
|
-0.04
+20%
|
-0.02
+50%
|
-0.01
+50%
|
0
N/A
|
0.01
N/A
|
0.01
N/A
|
|